Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Peregrine Pharmaceuticals to Implement 1:5 Reverse Stock Split on Monday

Peregrine Pharmaceuticals to Implement 1:5 Reverse Stock Split on Monday

posted on Oct 19, 2009 01:11AM
Share
New Message
Please login to post a reply